Article
The prognostic power of gene mutations in thyroid cancer
11 Dec 2023
Abstract excerpt
The introduction and generalization of next-generation sequencing techniques have significantly increased the identification of mutations in thyroid tumors from multiple patient cohorts. The understanding of the association between specific mutations and clinical outcomes is gradually leading to individualizing the care of patients with thyroid cancer. BRAFV600 is the most common mutation seen in thyroid cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.